Phase 1: Lartesertib and Tuvusertib Target DNA Repair to Fight Resistant Tumors
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxAlpha DaRT: A Promising Frontier in the Treatment of Prostate, Bladder, and Advanced Cancers
/0 Comments/in Clinical Trial, Localized, Metastatic/by MaxOMNIRAY: a Phase 1 Clinical Trial for LY4257496 for mCRPC
/0 Comments/in Clinical Trial, Metastatic, Phase 1/by MaxThe OMNIRAY trial will be investigating LY4257496, a novel radioligand therapy and it is set to begin in August 2025. This phase 1a/1b, multicenter, open-label study aims to establish the safety, tolerability and dosimetry of LY4257496 in adult patients bearing advanced solid tumors that express the gastrin-releasing peptide receptor (GRPR). The trial proposes a two-part […]
Nuanced Benefits of Fasting-Mimicking Diets: High Protein vs. Low Protein
/0 Comments/in Clinical Trial/by MaxA recent study published in Clinical Nutrition sheds new light on the physiological impacts of Fasting-Mimicking Diets (FMDs), revealing that while both low-protein and high-protein versions offer significant health advantages, their specific benefits can differ notably. This randomized controlled trial explored the effects of a 7-day plant-based FMD with either a low protein/high fat (LP-FMD) […]
Immunotherapy Drug Eradicates Aggressive Cancers in Clinical Trial
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxUpdate: HLD-0915 Advances with FDA Fast Track Designation for Metastatic Castration-Resistant Prostate Cancer
/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by MaxTrial to Test If Intermittent Fasting Can Boost Prostate Cancer Treatment Efficacy
/0 Comments/in Clinical Trial, Localized, Metastatic, Phase 1, Phase 2/by MaxPhase 2 trial: Tarlatamab for Neuroendocrine Prostate Cancer (NEPC)
/0 Comments/in Clinical Trial, Metastatic, Phase 2/by MaxPhase Ib/II Study of TYK-00540 Combined With Enzalutamide in mCRPC
/0 Comments/in Clinical Trial, Metastatic, Phase 1, Phase 2/by MaxProject Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone acetate ADC AI ai in healthcare alphafold antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T clinical trial clinical trials crispr darolutamide drug repurposing drug resistance enzalutamide HRR immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STAMPEDE trial theranostics
Latest Posts
- Newsletter 37/2025 September 14, 2025
- OST-504: A Novel Immunotherapy Targeting Prostate Cancer September 13, 2025
- Memantine Shows Promise Against Advanced Prostate Cancer September 11, 2025
- Pasritamig in Late-Line Prostate Cancer: From Early Findings to the KLK2-comPAS Trial September 11, 2025